Product details

This Jordanian pharmaceutical firm faces major strategic challenges as new competition and Jordan''s recent membership into the World Trade Organisation (WTO) puts the firm''s entire product line in jeopardy. Founded to provide high quality pharmaceuticals at reasonable prices for the local and regional population, the company enjoyed Jordanian government permission to produce drugs whose formulation was patented overseas if they use their own production processes. Now international intellectual property rights and pharmaceutical patents will be honoured, and the competitive landscape is changing. In the face of such threats, the founder is considering a strategic alliance with a major European pharmaceutical firm. This case was developed with support from the US Agency for International Development (USAID) through the Institute of International Education. This case was sponsored by the Indiana University CIBER Case Collection.